CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

MeiraGTx strikes royalty deal; Fore's 2023 Series D continues

PartnershipPositive
AI Analysis

Summary

MeiraGTx announced a royalty deal with Oberland Capital involving an initial $135 million payment, which includes a $10 million equity investment in the gene therapy company.

Importance:5/10
Sentiment:
0.60
gene therapyfinancingroyalty dealequity investment
Related Companies

Read the original article

Published by Endpoints News on July 7, 2026 2:38 PM

Read Original